Shopping Cart 0
Cart Subtotal
USD 0

Texas A&M University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Texas A&M University (TAMU) is a research based university that provide educational and research services. The university offers undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences, College of Architecture, Mays Business School, Baylor College of Dentistry, College of Education and Human Development, engineering students testing a robotic device, Dwight Look College of Engineering, College of Geosciences and College of Veterinary Medicine and Biomedical Sciences, among others. TAMU also offers education in the field of law, liberal arts, medicine, public health and science, among others. The university provides undergraduate and graduate research programs. It operates in the US, Qatar, Mexico and Costa Rica. TAMU is headquartered in College Station, Texas, the US.

Texas A&M University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas A&M University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9

Texas A&M University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Texas A&M University, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Texas A&M University and Greffex Sign Research Agreement 11

Texas A&M University Enters into Agreement with iBio 12

Licensing Agreements 13

Celltex Therapeutics Enters into Licensing Agreement with Texas A&M Institute for Regenerative Medicine 13

Xoma Enters into Licensing Agreement with Texas A&M University System 14

Texas A&M University-Key Competitors 15

Texas A&M University-Key Employees 16

Texas A&M University-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Government and Public Interest 18

Apr 18, 2018: National Academies' Gulf Research Program Awards Over USD 340,000 to Assist Scientific Research Impacted by Hurricanes Harvey and Irma 18

Mar 05, 2018: Texas A&M Chemists Use Technology to Decode Language of Lipid-Protein Interaction 20

Feb 26, 2018: CPRIT awards more than USD 2.6 million to Texas A&M 23

Jan 10, 2018: Texas A&M Research shows Biological Clocks Could Improve Brain Cancer Treatmen 24

Dec 27, 2017: Technical University of Munich: Double strike against tuberculosis 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Texas A&M University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas A&M University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Texas A&M University, Pharmaceuticals & Healthcare, Key Facts 2

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas A&M University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas A&M University, Deals By Therapy Area, 2012 to YTD 2018 8

Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9

Texas A&M University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Texas A&M University and Greffex Sign Research Agreement 11

Texas A&M University Enters into Agreement with iBio 12

Celltex Therapeutics Enters into Licensing Agreement with Texas A&M Institute for Regenerative Medicine 13

Xoma Enters into Licensing Agreement with Texas A&M University System 14

Texas A&M University, Key Competitors 15

Texas A&M University, Key Employees 16

Texas A&M University, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Texas A&M University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.